Corsair Capital Management, L.P. Rockwell Medical, Inc. Transaction History
Corsair Capital Management, L.P.
- $377 Million
- Q1 2025
A detailed history of Corsair Capital Management, L.P. transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Corsair Capital Management, L.P. holds 55,000 shares of RMTI stock, worth $56,100. This represents 0.02% of its overall portfolio holdings.
Number of Shares
55,000
Previous 55,000
-0.0%
Holding current value
$56,100
Previous $62,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RMTI
# of Institutions
53Shares Held
7.13MCall Options Held
92.8KPut Options Held
14.9K-
Armistice Capital, LLC New York, NY2.37MShares$2.41 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$1.23 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$758,1210.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny453KShares$462,0610.0% of portfolio
-
Marshall Wace, LLP London, X0334KShares$340,2660.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $10.9M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...